Use este identificador para citar ou linkar para este item: https://repositorio.ufba.br/handle/ri/15905
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorMartins, Maria Tereza Silveira-
dc.contributor.authorSilva, Luciana Ferreira-
dc.contributor.authorKraychete, Angiolina Campos-
dc.contributor.authorReis, Dandara-
dc.contributor.authorDias, Lidiane-
dc.contributor.authorSchnitman, Gabriel-
dc.contributor.authorOliveira, Lívia-
dc.contributor.authorLopes, Gildete Barreto-
dc.contributor.authorLopes, Antonio Alberto da Silva-
dc.creatorMartins, Maria Tereza Silveira-
dc.creatorSilva, Luciana Ferreira-
dc.creatorKraychete, Angiolina Campos-
dc.creatorReis, Dandara-
dc.creatorDias, Lidiane-
dc.creatorSchnitman, Gabriel-
dc.creatorOliveira, Lívia-
dc.creatorLopes, Gildete Barreto-
dc.creatorLopes, Antonio Alberto da Silva-
dc.date.accessioned2014-09-09T15:00:28Z-
dc.date.available2014-09-09T15:00:28Z-
dc.date.issued2013-
dc.identifier.issn1471-2369-
dc.identifier.urihttp://repositorio.ufba.br/ri/handle/ri/15905-
dc.descriptionp. 1-10pt_BR
dc.description.abstractBackground: Despite the evidence that phosphate binder (PB) is associated with improved outcomes many hemodialysis patients do not adhere to prescribed PB regimen. Therefore, barriers to PB adherence should be identified and eliminated. The purpose of this study was to evaluate PB adherence among hemodialysis patients and to explore potentially modifiable factors associated with low PB adherence. Methods: A cross-sectional study (502 patients) was performed in four dialysis units in Salvador, Brazil, using data from the second phase of the Prospective Study of the Prognosis of Chronic Hemodialysis Patients (PROHEMO). Patients were categorized as adherent or non-adherent to PB based on their responses to a semi-structured questionnaire. Results: Non-adherence to PB was observed for 65.7% of the patients. After adjustments for numerous covariates, cerebrovascular disease (odds ratio (OR), 3.30; 95% confidence interval (CI), 1.03-10.61), higher PTH (OR per each 300 pg/mL, 1.14; 95% CI, 1.01-1.28), lack of comprehension of the appropriate time to use PB (OR, 7.09; 95% CI, 2.10-23.95) and stopping PB use after feeling better (OR, 4.54; 95% CI, 1.45-14.25) or feeling worse (OR, 11.04; 95% CI, 1.79- 68.03) were significantly associated with PB non-adherence. By contrast, the adjusted odds of PB non-adherence were lower for patients with more years on dialysis (OR by each 2 years, 0.87; 95% CI, 0.80-0.95), with serum phosphorus above 5.5 mg/dL (OR, 0.53; 95% CI 0.34-0.82), who referred that were encouraged by the dialysis staff to be independent (OR, 0.52; 95% CI 0.30-0.90), and reported that the nephrologist explained how PB should be used (OR, 0.20; 95% CI 0.05-0.73). Conclusion: The results of the present study are encouraging by showing evidence that improvement in the care provided by the dialysis staff and the attending nephrologist may play an important role in reducing the high prevalence of non-adherence to PB in maintenance hemodialysis patients. A new questionnaire is presented and may help to evaluate systematically the patients regarding PB adherence in hemodialysis setting.pt_BR
dc.language.isoenpt_BR
dc.rightsAcesso Abertopt_BR
dc.sourcehttp://dx.doi.org/10.1186/1471-2369-14-208pt_BR
dc.subjectHemodialysispt_BR
dc.subjectPhosphate binderpt_BR
dc.subjectAdherencept_BR
dc.titlePotentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysispt_BR
dc.title.alternativeBMC Nephrologypt_BR
dc.typeArtigo de Periódicopt_BR
dc.identifier.numberv. 14, n. 1pt_BR
dc.publisher.countryBrasilpt_BR
Aparece nas coleções:Artigo Publicado em Periódico (Faculdade de Medicina)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
1471-2369-14-208.pdf206,84 kBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.